Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Handbook of Experimental Pharmacology|March 13, 2021
The Kappa Opioid Receptor System in Temporal Lobe EpilepsyLuca Zangrandi, Christoph Schwarzer
British Journal of Pharmacology|March 2, 2016
The G-protein biased partial κ opioid receptor agonist 6'-GNTI blocks hippocampal paroxysmal discharges without inducing aversionLuca Zangrandi, Johannes Burtscher, James P MacKay, et al.
International Journal of Molecular Sciences|January 12, 2021
A Rationale for Hypoxic and Chemical Conditioning in Huntington's DiseaseJohannes Burtscher, Vittorio Maglione, Alba Di Pardo, et al.
Biomedicines|December 24, 2021
Functional Characterization of Spinocerebellar Ataxia Associated Dynorphin A Mutant PeptidesAndreas Lieb, Germana Thaler, Barbara Fogli, et al.
Frontiers in Molecular Neuroscience|October 16, 2018
Proenkephalin Derived Peptides Are Involved in the Modulation of Mitochondrial Respiratory Control During EpileptogenesisJohannes Burtscher, Camilla Bean, Luca Zangrandi, et al.
Frontiers in Pharmacology|November 14, 2024
Structure-function relationship of dynorphin B variants using naturally occurring amino acid substitutionsLuca Zangrandi, Barbara Fogli, Anna Mutti, et al.
International Journal of Molecular Sciences|August 7, 2021
Loss of mGluR5 in D1 Receptor-Expressing Neurons Improves Stress CopingLuca Zangrandi, Claudia Schmuckermair, Hussein Ghareh, et al.
Hippocampus|November 6, 2015
Sprouty2 and -4 hypomorphism promotes neuronal survival and astrocytosis in a mouse model of kainic acid induced neuronal damageSitthisak Thongrong, Barbara Hausott, Letizia Marvaldi, et al.
EMBO Molecular Medicine|September 6, 2019
Dynorphin-based "release on demand" gene therapy for drug-resistant temporal lobe epilepsyAlexandra S Agostinho, Mario Mietzsch, Luca Zangrandi, et al.
Pageof 2